Sign In
Buy IRTC
$117.17
-1.91 (-1.60%)
At Close: Jul 31, 2026
iRhythm Technologies, Inc. (IRTC) Q2 2025 Earnings Call Transcript
09:49pm, Thursday, 31'st Jul 2025
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Daniel G. Wilson - CFO & Principal Financial Officer Quentin S.
iRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates
06:41pm, Thursday, 31'st Jul 2025
iRhythm Technologies (IRTC) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to a loss of $0.61 per share a year ago.
iRhythm Technologies Announces Second Quarter 2025 Financial Results
04:05pm, Thursday, 31'st Jul 2025
SAN FRANCISCO, July 31, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preve
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues
Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know
11:07am, Thursday, 24'th Jul 2025
iRhythm Technologies (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025
04:30pm, Thursday, 17'th Jul 2025
SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict
NEW YORK and NEW ORLEANS , July 11, 2025 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
iRhythm Technologies Announces Board Member Retirements and New Director Appointments
08:30am, Monday, 07'th Jul 2025
SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and preven
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues
New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease
DOCS vs. IRTC: Who Will Win High-Stakes AI Showdown in Digital Health?
08:26am, Thursday, 19'th Jun 2025
DOCS and IRTC are redefining digital health with AI, but only one is winning big with investors in 2025's market surge.
Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to Dismiss
08:48pm, Tuesday, 17'th Jun 2025
iRhythm misled investors by promoting Zio AT as a real-time monitor for high-risk patients, inflating stock prices that dropped when the truth emerged.
SAN FRANCISCO , June 17, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises iRhythm Technologies, Inc. investors that the firm is investigating potential legal claims relating to alleged fal
NEW YORK CITY, NY / ACCESS Newswire / June 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Comp
NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Comp
